In addition, a recent study demonstrated that S100A4, S100A9, and S100A10 have a role in the inflammatory conditions, as well as the severity, of COVID-19 patients, and have the ability to influence the prognosis of the severe form of the disease [97]. This evidence concerns the gene S100A9 and COVID-19.